Nov 20, 2024, 19:12
Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer
A recent paper by Paolo Ciracì, Medical Oncology Resident at the University Hospital of Pisa, was mentioned by Nieves Martinez Lago, Medical Oncologist at the University Hospital Complex of Ferrol, on X:
“Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
- FTD/TPI+BEV, REG and FRU for unselected patients.
- Targeted Therapies for patients With Oncogenic Driver Molecular Alterations.
- Rechallenge antiEGFR in patients ctDNA RAS/BRAF wild-type.”
Authors: Paolo Ciracì, Vittorio Studiale, Ada Taravella, Carlotta Antoniotti, Chiara Cremolini.
For more posts like this, visit oncodaily.com.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:11